Ionophore application for artificial oocyte activation and its potential effect on morphokinetics: a sibling oocyte study.


Journal

Journal of assisted reproduction and genetics
ISSN: 1573-7330
Titre abrégé: J Assist Reprod Genet
Pays: Netherlands
ID NLM: 9206495

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 21 07 2021
accepted: 01 10 2021
pubmed: 14 10 2021
medline: 18 3 2022
entrez: 13 10 2021
Statut: ppublish

Résumé

To evaluate whether ionophore application at the oocyte stage changes the morphokinetics of the associated embryos in cases of artificial oocyte activation. In a prospective sibling oocyte approach, 78 ICSI patients with suspected fertilization problems had half of their MII-oocytes treated with a ready-to-use ionophore (calcimycin) immediately following ICSI (study group). Untreated ICSI eggs served as the control group. Primary analyses focused on morphokinetic behavior and the presence of irregular cleavages. The rates of fertilization, utilization, pregnancy, and live birth rate were also evaluated. Ionophore-treated oocytes showed a significantly earlier formation of pronuclei (t2PNa) and a better synchronized third cell cycle (s3) (P < .05). The rate of irregular cleavage was unaffected (P > .05). Ionophore treatment significantly improved the overall rates of fertilization (P < .01) and blastocyst utilization (P < .05). Ionophore application does not negatively affect cleavage timing nor is it associated with irregular cleavage.

Identifiants

pubmed: 34642877
doi: 10.1007/s10815-021-02338-3
pii: 10.1007/s10815-021-02338-3
pmc: PMC8666403
doi:

Substances chimiques

Ionophores 0
Calcimycin 37H9VM9WZL

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

3125-3133

Informations de copyright

© 2021. The Author(s).

Références

Fertil Steril. 2014 Oct;102(4):1029-1033.e1
pubmed: 25086787
Hum Reprod. 2017 Mar 1;32(3):485-491
pubmed: 28158511
J Assist Reprod Genet. 2012 Sep;29(9):891-900
pubmed: 22714134
Reprod Biomed Online. 2017 Dec;35(6):646-656
pubmed: 29074360
Hum Reprod. 2012 Feb;27(2):303-13
pubmed: 22166806
Fertil Steril. 2016 Feb;105(2):376-84.e9
pubmed: 26598211
Hum Reprod Open. 2020 Mar 19;2020(2):hoaa008
pubmed: 32206731
PLoS One. 2016 Dec 1;11(12):e0166398
pubmed: 27907016
Reprod Biomed Online. 2020 Feb;40(2):191-199
pubmed: 31983545
Fertil Steril. 2015 Dec;104(6):1452-9.e1-4
pubmed: 26409153
Hum Reprod. 2013 Dec;28(12):3215-21
pubmed: 24070998
Fertil Steril. 2020 Jul;114(1):163-174
pubmed: 32622408
J Assist Reprod Genet. 2015 Jul;32(7):1151-60
pubmed: 26174125
Reprod Biomed Online. 2015 Oct;31(4):476-8
pubmed: 26277587
Reprod Biomed Online. 2015 Apr;30(4):323-4
pubmed: 25841874
Fertil Steril. 2012 Dec;98(6):1432-7
pubmed: 22921909
Fertil Steril. 2014 Nov;102(5):1287-1294.e5
pubmed: 25217875
Hum Reprod. 2018 Sep 1;33(9):1636-1644
pubmed: 30099496
Fertil Steril. 2019 Aug;112(2):266-274
pubmed: 31133387
J Assist Reprod Genet. 2018 Jun;35(6):1005-1010
pubmed: 29392515
Fertil Steril. 2010 Aug;94(3):900-4
pubmed: 19464000
Reprod Biomed Online. 2017 Nov;35(5):511-520
pubmed: 28736152
Arch Gynecol Obstet. 2017 Dec;296(6):1199-1205
pubmed: 28932956
J Assist Reprod Genet. 2017 Aug;34(8):983-990
pubmed: 28573526
Reprod Biomed Online. 2014 Jan;28(1):54-63
pubmed: 24125944
Nat Biotechnol. 2010 Oct;28(10):1115-21
pubmed: 20890283
Fertil Steril. 2016 Mar;105(3):798-806.e2
pubmed: 26632207
Fertil Steril. 2016 Mar;105(3):807-814.e2
pubmed: 26658129
J Assist Reprod Genet. 2015 Jan;32(1):27-35
pubmed: 25370178
Hum Reprod. 2011 Jun;26(6):1270-83
pubmed: 21502182
Cochrane Database Syst Rev. 2019 May 29;5:CD011320
pubmed: 31140578
Hum Reprod. 2013 Jul;28(7):1776-82
pubmed: 23595971
PLoS One. 2017 Aug 25;12(8):e0183328
pubmed: 28841654
Dev Biol. 2003 Jun 15;258(2):464-74
pubmed: 12798302
Reprod Biomed Online. 2010 Apr;20(4):510-5
pubmed: 20129824
Reprod Biomed Online. 2016 Mar;32(3):271-3
pubmed: 26776820
Fertil Steril. 2018 Apr;109(4):665-674
pubmed: 29452698
Hum Reprod. 2018 Jan 1;33(1):23-31
pubmed: 29149327
Hum Reprod. 2004 Aug;19(8):1837-41
pubmed: 15166130
Fertil Steril. 2020 Dec;114(6):1207-1215
pubmed: 32861442
Reprod Biomed Online. 2021 Feb;42(2):332-339
pubmed: 33250413
Hum Reprod. 2015 Aug;30(8):1831-41
pubmed: 26082476
J Assist Reprod Genet. 2021 May;38(5):1061-1068
pubmed: 33619678
Reprod Biomed Online. 2011 Aug;23(2):234-44
pubmed: 21665548
J Assist Reprod Genet. 2021 Feb;38(2):531-537
pubmed: 33405007
Reprod Biomed Online. 2015 Apr;30(4):359-65
pubmed: 25596904
Hum Reprod. 2015 Jan;30(1):97-102
pubmed: 25376461
Fertil Steril. 2016 Sep 1;106(3):590-596.e2
pubmed: 27143515
Fertil Steril. 2009 Jan;91(1):133-9
pubmed: 18829025
Reprod Biomed Online. 2012 May;24(5):521-6
pubmed: 22417664
Hum Reprod Open. 2018 May 29;2018(3):hoy009
pubmed: 30895250
Reprod Biomed Online. 2015 Dec;31(6):799-804
pubmed: 26507280

Auteurs

Omar Shebl (O)

Department of Gynecology, Obstetrics, and Gynecological Endocrinology, Kepler University Hospital, MedCampus IV, Krankenhausstr. 26-30, A-4020, Linz, Upper Austria, Austria.

Philip Sebastian Trautner (PS)

Department of Gynecology, Obstetrics, and Gynecological Endocrinology, Kepler University Hospital, MedCampus IV, Krankenhausstr. 26-30, A-4020, Linz, Upper Austria, Austria.

Sabine Enengl (S)

Department of Gynecology, Obstetrics, and Gynecological Endocrinology, Kepler University Hospital, MedCampus IV, Krankenhausstr. 26-30, A-4020, Linz, Upper Austria, Austria.

Elisabeth Reiter (E)

Department of Gynecology, Obstetrics, and Gynecological Endocrinology, Kepler University Hospital, MedCampus IV, Krankenhausstr. 26-30, A-4020, Linz, Upper Austria, Austria.

Christina Allerstorfer (C)

Department of Gynecology, Obstetrics, and Gynecological Endocrinology, Kepler University Hospital, MedCampus IV, Krankenhausstr. 26-30, A-4020, Linz, Upper Austria, Austria.

Tamara Rechberger (T)

Department of Gynecology, Obstetrics, and Gynecological Endocrinology, Kepler University Hospital, MedCampus IV, Krankenhausstr. 26-30, A-4020, Linz, Upper Austria, Austria.

Peter Oppelt (P)

Department of Gynecology, Obstetrics, and Gynecological Endocrinology, Kepler University Hospital, MedCampus IV, Krankenhausstr. 26-30, A-4020, Linz, Upper Austria, Austria.

Thomas Ebner (T)

Department of Gynecology, Obstetrics, and Gynecological Endocrinology, Kepler University Hospital, MedCampus IV, Krankenhausstr. 26-30, A-4020, Linz, Upper Austria, Austria. Thomas.ebner@kepleruniklinikum.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH